TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22674493

Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation (PTNS)
Number of subjects: 50
Study: 21620376

Group type: EXPERIMENTAL
Intervention: Repeated checking of a virtual stovetop with novel stimuli (color changed every five trials)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Repeated checking of a virtual stovetop (standard stimulus)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Repeated checking of a different stimulus (not specified)
Number of subjects: 65
Study: 19366459

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 774

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 774
Study: 16450662

Group type: EXPERIMENTAL
Intervention: 4 mg ZOL every two weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: 4 mg ZOL every four weeks
Number of subjects: 60
Study: 15293159

Group type: COMPARATOR
Intervention: Tissucol (Group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Autologous fibrin glue (Group B)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 11368195

Group type: EXPERIMENTAL
Intervention: 10-session behavioral intervention introducing female-initiated methods of HIV prevention
Number of subjects: 35

Group type: COMPARATOR
Intervention: HIV education control
Number of subjects: 35
Study: 7480054

Group type: EXPERIMENTAL
Intervention: Compression treatment
Number of subjects: 0
Study: 2333541

Group type: EXPERIMENTAL
Intervention: Premedicated with intramuscular atropine 0.015 mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-premedicated patients
Number of subjects: 80
Study: 356683

Group type: EXPERIMENTAL
Intervention: Flunisolide nasal spray (150 microgram/day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 31483941

Group type: EXPERIMENTAL
Intervention: LED‐RL at fluences of 160-640 J/cm2 (STARS 1)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: LED‐RL at fluences of 480-640 J/cm2 (STARS 2)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Mock irradiation
Number of subjects: 115
Study: 30671945

Group type: EXPERIMENTAL
Intervention: Family Nurture Intervention (FNI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard NICU care
Number of subjects: 0
Study: 28418937

Group type: EXPERIMENTAL
Intervention: Wrist Continuous Noninvasive Arterial Pressure Monitoring (CNAP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Invasive Arterial Pressure Monitoring (IAP)
Number of subjects: 60
Study: 25112307

Group type: EXPERIMENTAL
Intervention: Brief intervention (BI) involving feedback about individual risk of MOH and how to reduce overuse.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Business as usual (BAU) control group.
Number of subjects: 60
Study: 24021837

Group type: EXPERIMENTAL
Intervention: Normalized amplitude thresholding method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current standard thresholding methods
Number of subjects: 0
Study: 22480552

Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fastrach ILMA
Number of subjects: 80
Study: 20231682

Group type: EXPERIMENTAL
Intervention: Presence of Eastern Cooperative Oncology Group performance status (PS) more than 0
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Hemoglobin level less than 10 g/dL
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Presence of liver metastasis
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Zero prognostic factors
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: One prognostic factor
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Two prognostic factors
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Three prognostic factors
Number of subjects: 370
Study: 17339234

Group type: EXPERIMENTAL
Intervention: Asoprisnil 10 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Asoprisnil 25 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 16291107

Group type: EXPERIMENTAL
Intervention: Assisted spinal manipulation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Unassisted spinal manipulation
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Assisted joint preload force
Number of subjects: 34

Group type: COMPARATOR
Intervention: Unassisted joint preload force
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: L5-S1 side-posture SM
Number of subjects: 34

Group type: COMPARATOR
Intervention: Side-posture positioning maneuver
Number of subjects: 34
Study: 12224691

Group type: EXPERIMENTAL
Intervention: Systemic corticosteroids with orally administered prednisone (group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Systemic corticosteroids alternating a pulse of intravenous betamethasone with orally administered prednisone (group B)
Number of subjects: 20
Study: 10320384

Group type: EXPERIMENTAL
Intervention: Valacyclovir (2 g orally four times daily for 90 days)
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Valacyclovir
Number of subjects: 616

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 616
Study: 8907140

Group type: EXPERIMENTAL
Intervention: morphine sulfate solution or controlled‐release morphine tablets
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: morphine administration
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: morphine plus M6G concentrations in the optimal control group
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: morphine plus M6G plasma concentrations
Number of subjects: 39
Study: 1986523

Group type: EXPERIMENTAL
Intervention: Orthodontic extrusion for 1, 2, or 4 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (contralateral maxillary first premolars not extruded)
Number of subjects: 36
Study: 6849724

Group type: EXPERIMENTAL
Intervention: Chlormethiazole (mean 6.0 mg kg‐1)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Thiopentone (mean 4.5 mg kg‐1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chlormethiazole
Number of subjects: 16

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 16
Study: 31930896

Group type: EXPERIMENTAL
Intervention: Bloodletting acupuncture at jing-well points combined with routine acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 60
Study: 31393619

Group type: EXPERIMENTAL
Intervention: L-carnitine (6 g/L)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-carnitine (12 g/L)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no L-carnitine)
Number of subjects: 0
Study: 30156033

Group type: EXPERIMENTAL
Intervention: Combined exercise regimen (Comb-Ex)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: High-protein diet (HP diet)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both groups (HP diet and Comb-Ex)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Neither group
Number of subjects: 11
Study: 27610025

Group type: EXPERIMENTAL
Intervention: EMVI-positive patients
Number of subjects: 194

Group type: COMPARATOR
Intervention: EMVI-negative patients
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: ctEMVI
Number of subjects: 194
Study: 24508782

Group type: EXPERIMENTAL
Intervention: rilpivirine/emtricitabine/tenofovir disoproxil fumarate (RPV/FTC/TDF)
Number of subjects: 786

Group type: COMPARATOR
Intervention: efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF)
Number of subjects: 786
Study: 22992012

Group type: EXPERIMENTAL
Intervention: Pro-inflammatory cytokines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory cytokines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytokines
Number of subjects: 0
Study: 19442381

Group type: EXPERIMENTAL
Intervention: Suprafascial dissection with sheet graft reconstruction
Number of subjects: 62

Group type: COMPARATOR
Intervention: Suprafascial dissection with meshed graft reconstruction
Number of subjects: 62

Group type: COMPARATOR
Intervention: Subfascial dissection with meshed graft reconstruction
Number of subjects: 62

Group type: COMPARATOR
Intervention: Subfascial dissection with sheet graft reconstruction
Number of subjects: 62
Study: 17316098

Group type: EXPERIMENTAL
Intervention: Web-based intervention plus usual care
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 62
Study: 15347711

Group type: EXPERIMENTAL
Intervention: 3D stereotactic surface projection (3D-SSP) technique
Number of subjects: 38

Group type: COMPARATOR
Intervention: Visual inspection
Number of subjects: 38
Study: 11673331

Group type: EXPERIMENTAL
Intervention: Pattern adaptation (motion after-effect and tilt after-effect) in migraine sufferers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Headache-free control subjects
Number of subjects: 0
Study: 9541124

Group type: EXPERIMENTAL
Intervention: Infusion of [14C]-palmitate for 60 min (study A)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Infusion of [14C]-palmitate for 10 min (study B)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Infusion of [14C]-palmitate for 60 min (study A) and 10 min (study B)
Number of subjects: 12
Study: 9078536

Group type: EXPERIMENTAL
Intervention: Oral glucose (30 g)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (i.v. glucose infusion without oral glucose)
Number of subjects: 8
Study: 2667597

Group type: EXPERIMENTAL
Intervention: Nicardipine 40 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propranolol 80 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nicardipine 30 mg plus Propranolol 40 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nicardipine 20 mg plus Propranolol 40 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nicardipine 30 mg plus Propranolol 80 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nicardipine monotherapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propranolol monotherapy
Number of subjects: 60
Study: 3197

Group type: EXPERIMENTAL
Intervention: Nalorphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heroin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 31808180

Group type: EXPERIMENTAL
Intervention: E-learning intervention on parenteral nutrition
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no e-learning)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Iterative tests in HOSP1
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: E-learning satisfaction
Number of subjects: 65
Study: 31591676

Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate with monoethyl fumarate salts
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 27292167

Group type: EXPERIMENTAL
Intervention: Ropivacaine 7.5 mg/ml
Number of subjects: 68

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 68
Study: 26507554

Group type: EXPERIMENTAL
Intervention: SASA! intervention to prevent violence against women
Number of subjects: 0
Study: 23277421

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist-led pharmaceutical care in addition to standard care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0
Study: 20947210

Group type: EXPERIMENTAL
Intervention: Ketamine/propofol
Number of subjects: 136

Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 136
Study: 19223439

Group type: EXPERIMENTAL
Intervention: Secretin (RG1068; 20 microg/kg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline placebo (20 microg/kg)
Number of subjects: 25
Study: 16823250

Group type: EXPERIMENTAL
Intervention: Low-frequency electrical stimulation (LFES) for 8 weeks, 1 hour/day, 7 days/week
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bicycle training for 8 weeks, 40 minutes, 3 times a week
Number of subjects: 30
Study: 12919708

Group type: EXPERIMENTAL
Intervention: 5 mg of alendronate daily plus progressive jumping exercise
Number of subjects: 164

Group type: COMPARATOR
Intervention: 5 mg alendronate
Number of subjects: 164

Group type: COMPARATOR
Intervention: placebo plus progressive jumping exercise
Number of subjects: 164

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 164
Study: 10772184

Group type: EXPERIMENTAL
Intervention: 30 g of oral glutamine daily
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 9291287

Group type: COMPARATOR
Intervention: Local nasal immunotherapy (LNIT) with extracts in powder, administered pre-seasonally.
Number of subjects: 0
Study: 8317653

Group type: EXPERIMENTAL
Intervention: Local anaesthesia
Number of subjects: 169

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 169
Study: 3823668

Group type: EXPERIMENTAL
Intervention: Questionnaires with only factual questions
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Questionnaires sent by a government organization
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Questionnaires with precoded answers
Number of subjects: 1600
Study: 30126437

Group type: EXPERIMENTAL
Intervention: Multi-strategy practice change intervention including leadership support, local clinical practice guidelines, electronic prompts and reminders, opinion leaders, academic detailing, educational meetings, educational materials, and performance monitoring.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-strategy practice change intervention
Number of subjects: 0
Study: 26951923

Group type: EXPERIMENTAL
Intervention: Hydrophilic catheter
Number of subjects: 50

Group type: COMPARATOR
Intervention: PVC catheter
Number of subjects: 50
Study: 24907632

Group type: EXPERIMENTAL
Intervention: One-person Simon Says tasks
Number of subjects: 74

Group type: COMPARATOR
Intervention: Two-person Simon Says tasks
Number of subjects: 74

Group type: COMPARATOR
Intervention: Bear-Dragon task
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Presence of experimenter's movements
Number of subjects: 74
Study: 22049177

Group type: EXPERIMENTAL
Intervention: High protein and high dairy (HPHD)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Adequate protein and medium dairy (APMD)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Adequate protein and low dairy (APLD)
Number of subjects: 90
Study: 20452705

Group type: EXPERIMENTAL
Intervention: SBT with CPAP
Number of subjects: 50

Group type: COMPARATOR
Intervention: SBT with T-piece
Number of subjects: 50
Study: 18021826

Group type: EXPERIMENTAL
Intervention: Freegenol provisional cement enriched with chlorhexidine diacetate (CHDA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Temp Bond provisional cement with chlorhexidine diacetate (CHDA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Temp Bond NE provisional cement with chlorhexidine diacetate (CHDA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no luting agent)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All tested cements with chlorhexidine diacetate (CHDA)
Number of subjects: 12
Study: 16095478

Group type: EXPERIMENTAL
Intervention: Five treatments for neurotic disorders (specific treatments not detailed)
Number of subjects: 210
Study: 12444376

Group type: EXPERIMENTAL
Intervention: Prophylactic injection therapy with 1% aethoxysclerol, intravenous 40 mg omeprazole twice a day, and somatostatin infusion at the dose of 6 mg/day during 3 days (group-1)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Medical treatment with the same agents and doses without perendoscopic therapy (group-2)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Prophylactic injection therapy with 1% aethoxysclerol (group-1)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Medical treatment without perendoscopic therapy (group-2)
Number of subjects: 52
Study: 10090348

Group type: EXPERIMENTAL
Intervention: Nisoldipine CC (10 mg to 40 mg daily)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Enalapril (10 mg to 40 mg daily)
Number of subjects: 96
Study: 7598297

Group type: EXPERIMENTAL
Intervention: No routine ventilator circuit changes
Number of subjects: 300

Group type: COMPARATOR
Intervention: Circuit changes every 7 days
Number of subjects: 300
Study: 2240672

Group type: EXPERIMENTAL
Intervention: Midazolam 0.75 mg.kg-1 po and atropine 0.03 mg.kg-1 po
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Midazolam 0.50 mg.kg-1 po and atropine 0.03 mg.kg-1 po
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo (containing the midazolam vehicle, atropine, and apple juice)
Number of subjects: 124
Study: 29450585

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (1000 IU/day, orally)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 25763988

Group type: EXPERIMENTAL
Intervention: Low-intensity, clinic-integrated behavioural intervention
Number of subjects: 390

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 390
Study: 25398189

Group type: EXPERIMENTAL
Intervention: Improved chimney stoves
Number of subjects: 456

Group type: COMPARATOR
Intervention: Traditional cookstoves
Number of subjects: 456
Study: 23375025

Group type: EXPERIMENTAL
Intervention: Rilonacept 320 mg SC plus indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days
Number of subjects: 225

Group type: COMPARATOR
Intervention: Indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Rilonacept 320 mg SC plus oral placebo
Number of subjects: 225
Study: 21932656

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 228

Group type: COMPARATOR
Intervention: Chisel osteotomy
Number of subjects: 228
Study: 19363054

Group type: EXPERIMENTAL
Intervention: RVS pacing with VRR
Number of subjects: 24

Group type: COMPARATOR
Intervention: RVA pacing with VRR
Number of subjects: 24
Study: 17004672

Group type: EXPERIMENTAL
Intervention: Supplemental reading intervention daily for 50 minutes in small groups from October to April
Number of subjects: 0

Group type: COMPARATOR
Intervention: School's existing instructional program for struggling readers
Number of subjects: 0
Study: 15005325

Group type: EXPERIMENTAL
Intervention: Magnetic induction (MI) low-cost system to measure liver iron overload; excitation magnetic field (B0, frequency: 28 kHz) produced by a coil.
Number of subjects: 17

Group type: COMPARATOR
Intervention: Plastic tanks filled with water, saline, and ferric solutions for calibration purposes.
Number of subjects: 17
Study: 11314793

Group type: EXPERIMENTAL
Intervention: rhOP‐1 (BMP‐7) with type I collagen carrier
Number of subjects: 122

Group type: COMPARATOR
Intervention: Fresh autogenous bone
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 122
Study: 9249116

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil (ITS) 12.5 microg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil (ITS) 25 microg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil (ITS) 50 microg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All doses of ITS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Supplemental oxygen by nasal cannula
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Serum sufentanil concentrations
Number of subjects: 18
Study: 8293750

Group type: EXPERIMENTAL
Intervention: Iodixanol 320 mgI/ml
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ioxaglate 320 mgI/ml
Number of subjects: 80
Study: 3501994

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 30696306

Group type: COMPARATOR
Intervention: Indomethacin plus placebo
Number of subjects: 150

Group type: COMPARATOR
Intervention: Nifedipine plus placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combination of indomethacin and nifedipine
Number of subjects: 150
Study: 29420695

Group type: EXPERIMENTAL
Intervention: 1 tablet daily
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: 1 tablet twice weekly with a postsex dose (time‐driven)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: 1 tablet before and after sex (event‐driven)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Daily arm
Number of subjects: 357
Study: 27733325

Group type: EXPERIMENTAL
Intervention: TAP (transversus abdominis plane block)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TAP+perineural dexamethasone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 25555877

Group type: EXPERIMENTAL
Intervention: General anesthesia combined SGB group (group S, n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: General anesthesia group (group N, n=15)
Number of subjects: 30
Study: 23312702

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 20845241

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 18837864

Group type: EXPERIMENTAL
Intervention: Bifrontal ECT (BFECT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bitemporal ECT (BTECT)
Number of subjects: 36
Study: 17003293

Group type: EXPERIMENTAL
Intervention: Basal insulin discontinued during exercise
Number of subjects: 49

Group type: COMPARATOR
Intervention: Basal insulin continued during exercise
Number of subjects: 49
Study: 15535808

Group type: EXPERIMENTAL
Intervention: Meaningful irrelevant speech
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Road traffic noise
Number of subjects: 96

Group type: COMPARATOR
Intervention: Silent condition
Number of subjects: 96
Study: 11754399

Group type: EXPERIMENTAL
Intervention: Acenocoumarol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 9282234

Group type: EXPERIMENTAL
Intervention: High-dose inhaled ipratropium bromide (total dose of 144 micrograms)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oral aminophylline (400 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Inhaled placebo and placebo tablets
Number of subjects: 18
Study: 8102213

Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol 4 mg after placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol 4 mg after placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Inhaled fenoterol 4 mg after atenolol
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol 4 mg after atenolol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Inhaled fenoterol and salbutamol at both doses
Number of subjects: 14